Drug development is no longer linear.
The pressure to identify high-potential assets before data maturity or clinical precedent is forcing teams to act on less. However, high-performing organizations do not necessarily generate more data. They are using existing evidence more effectively.
This free guide covers insights, considerations, and strategic ideas related to leveraging peer-reviewed research in drug development. Topics covered include:
- Identifying and validating promising targets
- Choosing more predictive models
- Avoiding known translational pitfalls
- Moving into the clinic with greater confidence
